Eurofins bioskin GmbH

Since 1992, Eurofins bioskin is a leading dermatology CRO with unique understanding and capabilities for tailor-made pharmaceutical clinical trials in healthy volunteers and patients. Recognized by global companies as a valuable, strategic partner for development programs on drugs, medical devices, food supplements and aesthetics, bioskin provides early phase safety and Proof-of-Concept studies; vasoconstrictor assays according to FDA guideline; and global Phase II - IV trials for NCEs, new formulations with known actives and generics.